Bayer's commitment
Patient information
You can download the following files in PDF format :
Summary of Product Characteristics Prescribing Information Patient Information Leaflet
For more than three decades, Bayer has focused on delivering state-of-the-art treatment options for people living with haemophilia.
At Bayer we're following through on our pledge by investing millions every year to improve the lives of people living with haemophilia. Bayer currently funds research and a variety of educational and recreational services for haemophilia patients and their families. We also provide significant financial support to the programmes and initiatives of professional organisations, academic societies, safety councils, and patient advocacy groups.
ClinicalTrials.gov
Find out about ongoing trials in haemophilia by visiting ClinicalTrials.gov
Bayer Haemophilia Awards
For more information about the programme click here